Buprenorphine: opioid receptor partial agonist (μ),receptor antagonist (κ,d). Naloxone: opioid antagonist (μ).

  • Opioid
  • May improve depression in patients with opioid use disorder

Dosing

See guide below.

Management

EMR Text

Opioid Use Disorder

Buprenorphine use based on FDA approval in opioid use disorder.

Buprenorphine’s risks and side effects, including dosing and precipitated withdrawal, reviewed with patient.

Scroll to Top